| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849369 | American Heart Journal | 2014 | 8 Pages |
Abstract
Most DM patients were prescribed non-DM-friendly β-blockers-a practice that was associated with a trend toward worse glycemic control postdischarge. Although in need of further confirmation in larger studies, our findings highlight an opportunity to improve current practices of β-blockers use in patients with DM.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Suzanne V. MD, MHA, John A. MD, MPH, Kasia J. MD, David E. MD, Fengming MS, Anna MD, Darren K. MD, MHSc, M. Odette MD, Abhinav MD, MHS, Thomas M. MD, MSc, Mikhail MD,